Cargando…

Pharmacogenetics of anticancer monoclonal antibodies

Pharmacogenetics is the study of therapeutic and adverse responses to drugs based on an individual’s genetic background. Monoclonal antibodies (mAbs) are a rapidly evolving field in cancer therapy, however a number of newly developed and highly effective mAbs (e.g., anti-CTLA-4 and anti-PD-1) posses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shek, Dmitrii, Read, Scott A., Ahlenstiel, Golo, Piatkov, Irina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OAE Publishing Inc. 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019180/ https://www.ncbi.nlm.nih.gov/pubmed/35582142 http://dx.doi.org/10.20517/cdr.2018.20

Ejemplares similares

Immune-Checkpoint Inhibitors for Metastatic Colorectal Cancer: A Systematic Review of Clinical Outcomes
por: Shek, Dmitrii, et al.
Publicado: (2021)

The Role of Zinc in Antiviral Immunity
por: Read, Scott A, et al.
Publicado: (2019)

Pharmacogenetics and Gender Association with Psychotic Episodes on Nortriptyline Lower Doses: Patient Cases
por: Piatkov, Irina, et al.
Publicado: (2011)

Reprogramming—Evolving Path to Functional Surrogate β-Cells
por: Kalo, Eric, et al.
Publicado: (2022)

Cases of Adverse Reaction to Psychotropic Drugs and Possible Association with Pharmacogenetics
por: Piatkov, Irina, et al.
Publicado: (2012)

The Role of Gut-Derived Microbial Antigens on Liver Fibrosis Initiation and Progression
por: Chen, Dishen, et al.
Publicado: (2019)

Identification and Characterisation of Infiltrating Immune Cells in Malignant Pleural Mesothelioma Using Spatial Transcriptomics
por: Shek, Dmitrii, et al.
Publicado: (2023)

The Natural Killer Cell Response to HCV Infection
por: Ahlenstiel, Golo
Publicado: (2013)

Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics
por: Adhikari, Archana, et al.
Publicado: (2021)

Pharmacogenetics of anticancer drugs in non-Hodgkin lymphomas
por: Loni, L, et al.
Publicado: (2001)

The Role of Micronutrients in the Infection and Subsequent Response to Hepatitis C Virus
por: Gupta, Sunil, et al.
Publicado: (2019)

Immunomodulation of the Natural Killer Cell Phenotype and Response during HCV Infection
por: Njiomegnie, Gaitan Fabrice, et al.
Publicado: (2020)

Evolution of risk prediction models for post-operative mortality in patients with cirrhosis
por: Kalo, Eric, et al.
Publicado: (2023)

Interferon-λ3 Exacerbates the Inflammatory Response to Microbial Ligands: Implications for SARS-CoV-2 Pathogenesis
por: Read, Scott A, et al.
Publicado: (2021)

Pharmacogenomics of hepatitis C infections: personalizing therapy
por: Booth, David R, et al.
Publicado: (2012)

Personalized Medicine of Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacogenetics, Therapeutic Drug Monitoring, and Beyond
por: Di Paolo, Antonello, et al.
Publicado: (2021)

A novel, nurse-led ‘one stop’ clinic for patients with liver cirrhosis results in fewer liver-related unplanned readmissions and improved survival
por: Kalo, Eric, et al.
Publicado: (2023)

EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
por: Francescon, Sara, et al.
Publicado: (2018)

The Use of Two-Dimensional Shear Wave Elastography in People with Obesity for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Chimoriya, Ritesh, et al.
Publicado: (2020)

Pharmacogenetics of thiopurines
por: Franca, Raffaella, et al.
Publicado: (2019)

The pharmacogenetics of imatinib
por: Dulucq, Stéphanie, et al.
Publicado: (2010)

Experimental Pharmacogenetics
por: Lubs, Herbert A.
Publicado: (1964)

Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping
por: Montrasio, Cristina, et al.
Publicado: (2023)

Digital Health Applications for Pharmacogenetic Clinical Trials
por: Naik, Hetanshi, et al.
Publicado: (2020)

Pharmacogenetics of Anticoagulants
por: Rane, Anders, et al.
Publicado: (2010)

Pharmacogenetics of osteoporosis
por: Marini, Francesca, et al.
Publicado: (2010)

Pharmacogenetics of Cannabinoids
por: Hryhorowicz, Szymon, et al.
Publicado: (2017)

In vitro and in vivo anticancer efficacy of unconjugated humanised anti-CEA monoclonal antibodies
por: Blumenthal, R D, et al.
Publicado: (2008)

Monoclonal Antibodies in Cancer
por: Ghosh, A.K.
Publicado: (1986)

A Multimodal Genotoxic Anticancer Drug Characterized by Pharmacogenetic Analysis in Caenorhabditis elegans
por: Ye, Frank B., et al.
Publicado: (2020)

Pharmacogenetics of asthma in children
por: Kondo, Naomi, et al.
Publicado: (2010)

Pharmacogenetics of lipid diseases
por: Ordovas, Jose M
Publicado: (2004)

Application of pharmacogenetics in oncology
por: Miteva-Marcheva, Nelly N., et al.
Publicado: (2020)

The Potential Utility of Pharmacogenetic Testing in Psychiatry
por: Gardner, Kathryn R., et al.
Publicado: (2014)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies
por: Struble, Evi B., et al.
Publicado: (2023)

Reply: In vitro and in vivo anticancer efficacy of unconjugated humanised anti-CEA monoclonal antibodies
por: Ashraf, S Q, et al.
Publicado: (2008)

Microbials for the production of monoclonal antibodies and antibody fragments
por: Spadiut, Oliver, et al.
Publicado: (2014)

Zinc is a potent and specific inhibitor of IFN-λ3 signalling
por: Read, Scott A., et al.
Publicado: (2017)

Monoclonal Antibodies in Cancer Therapy
por: Zahavi, David, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qn5g638lirmi4agrojvi71f4h5